AtriCure, Inc. ATRC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.79% | 13.94% | 15.01% | 14.88% | 15.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.79% | 13.94% | 15.01% | 14.88% | 15.80% |
| Cost of Revenue | 5.32% | 6.79% | 11.14% | 13.56% | 15.41% |
| Gross Profit | 16.64% | 16.35% | 16.32% | 15.32% | 15.94% |
| SG&A Expenses | 7.70% | 7.94% | 8.28% | 6.75% | 6.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.14% | 4.25% | 7.76% | 7.65% | 13.09% |
| Operating Income | 164.38% | 137.83% | 91.53% | 76.39% | 22.53% |
| Income Before Tax | 158.21% | 134.29% | 91.21% | 76.73% | 26.37% |
| Income Tax Expenses | 38.75% | 41.73% | 23.33% | 25.49% | -16.27% |
| Earnings from Continuing Operations | 151.73% | 129.02% | 87.97% | 74.39% | 26.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 151.73% | 129.02% | 87.97% | 74.39% | 26.07% |
| EBIT | 164.38% | 137.83% | 91.53% | 76.39% | 22.53% |
| EBITDA | 714.99% | 339.93% | 213.18% | 152.09% | 61.36% |
| EPS Basic | 150.30% | 128.24% | 88.09% | 74.67% | 26.93% |
| Normalized Basic EPS | 156.68% | 133.43% | 91.28% | 76.23% | 24.49% |
| EPS Diluted | 148.65% | 127.04% | 87.42% | 74.10% | 26.36% |
| Normalized Diluted EPS | 156.11% | 133.18% | 91.14% | 76.12% | 24.49% |
| Average Basic Shares Outstanding | 1.94% | 1.87% | 1.80% | 1.67% | 1.59% |
| Average Diluted Shares Outstanding | 3.40% | 2.83% | 2.67% | 2.16% | 1.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |